HB Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.44M Buy
350,351
+6,362
+2% +$166K 0.05% 191
2026
Q1
$9.66M Buy
343,989
+15,142
+5% +$403K 0.06% 161
2025
Q4
$8.19M Sell
328,847
-3,356
-1% -$84.6K 0.05% 180
2025
Q3
$8.46M Buy
332,203
+40,675
+14% +$1M 0.06% 178
2025
Q2
$7.07M Buy
291,528
+42,200
+17% +$984K 0.06% 178
2025
Q1
$6.32M Buy
249,328
+50,968
+26% +$1.33M 0.05% 189
2024
Q4
$5.26M Sell
198,360
-1,254
-0.6% -$34K 0.05% 158
2024
Q3
$5.78M Buy
199,614
+10,611
+6% +$310K 0.06% 142
2024
Q2
$5.29M Sell
189,003
-237
-0.1% -$6.53K 0.06% 143
2024
Q1
$5.25M Buy
189,240
+25,493
+16% +$707K 0.07% 145
2023
Q4
$4.71M Sell
163,747
-41,434
-20% -$1.25M 0.07% 141
2023
Q3
$6.81M Sell
205,181
-1,724
-0.8% -$61K 0.11% 95
2023
Q2
$7.59M Buy
206,905
+6,836
+3% +$266K 0.12% 91
2023
Q1
$8.16M Sell
200,069
-141,341
-41% -$6.1M 0.14% 76
2022
Q4
$17.5M Buy
341,410
+309
+0.1% +$14.8K 0.32% 37
2022
Q3
$14.9M Buy
341,101
+72,680
+27% +$3.53M 0.32% 34
2022
Q2
$14.1M Buy
268,421
+16,956
+7% +$864K 0.29% 34
2022
Q1
$13M Buy
251,465
+30,768
+14% +$1.6M 0.24% 40
2021
Q4
$13M Buy
+220,697
New +$10.9M 0.26% 36

Other funds holding PFE

HB Wealth Management's PFE Position: Q2 2026 in Review

HB Wealth Management increased its Pfizer (PFE) stake by 1.8% in Q2 2026, buying an estimated $166K and bringing the position to 350,351 shares worth $8.44M. The position accounts for 0.05% of the portfolio, ranked #191.

HB Wealth Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $17.5M in Q4 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • HB Wealth Management held 350,351 shares of Pfizer worth $8.44M as of Q2 2026.
  • HB Wealth Management bought 6,362 Pfizer shares in Q2 2026, an estimated $166K.
  • Pfizer made up 0.05% of HB Wealth Management's portfolio in Q2 2026, its #191 holding.
  • HB Wealth Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • HB Wealth Management's Pfizer position peaked at $17.5M in Q4 2022.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.